Plasma Fractionation Global Market Research Scope, Commercial Analysis and Forecast to 2022
ReportsWeb.com published “Plasma Fractionation Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, May 03, 2017 ) According to Publisher, the Global Plasma Fractionation Market is accounted for $16.87 billion in 2015 and is expected to reach $28.03 billion by 2022 growing at a CAGR of 7.5% during the forecast period. Factors such as rising geriatric population and increasing number of hemophilic patients are boosting the market growth. However, strict government rules, huge cost and limited reimbursements are some of the factors hampering the market. Rising digit of Hemophilic Patients is creating growth opportunities for vendors in the market.
For more information http://www.reportsweb.com/plasma-fractionation-global-market-outlook-2016-2022
By product, immunoglobulin segment dominated the global market with largest share in 2013 owing to growing geriatric population with neurological and autoimmune disease. By region, North America accounted for largest market share followed by Europe. However, Asia-Pacific is anticipated to grow at the highest CAGR owing to increasing digit of hemophilic patients and rising awareness of technologically advanced products in this region.
Some of the key players in Plasma Fractionation market include Octapharma AG, Chinese Biological Products, Inc., Baxter International, Inc., Bio Products Laboratory, Grifols International SA, Shanghai Raas Blood Products Co., Ltd, Csl, Ltd., China Biologic Products, Inc., Kedrion S.P.A., Biotest, Sanquin and LFB SA.
Applications Covered:
- Rheumatology
- Immunology
- Haemato-oncology
- Critical Care
- Neurology
- Pulmonology
- Haematology
- Other Applications
End Users Covered:
- Academic Institutes
- Hospitals and Clinics
- Clinical Research Laboratories
Products Covered:
- Protease Inhibitors
- Coagulation Factor Concentrates
o Prothrombin Complex Concentrates
o Factor IX
o Von Willebrand Factor (VWF)
o Factor VIII
o Fibrinogen Concentrates
o Factor XIII
- Fractionation Process
- Albumin
- Immunoglobulin
o Subcutaneous Immunoglobulin
o Intravenous Immunoglobulin
o Other Immunoglobulins
- Other Plasma Products
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564972/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
10 Company Profiling
10.1 Octapharma AG
10.2 Chinese Biological Products, Inc.
10.3 Baxter International, Inc.
10.4 Bio Products Laboratory
10.5 Grifols International SA
10.6 Shanghai Raas Blood Products Co., Ltd
10.7 Csl, Ltd.
10.8 China Biologic Products, Inc.
10.9 Kedrion S.P.A.
10.10 Biotest
10.11 Sanquin
10.12 LFB SA
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564972/buying
For more information http://www.reportsweb.com/plasma-fractionation-global-market-outlook-2016-2022
By product, immunoglobulin segment dominated the global market with largest share in 2013 owing to growing geriatric population with neurological and autoimmune disease. By region, North America accounted for largest market share followed by Europe. However, Asia-Pacific is anticipated to grow at the highest CAGR owing to increasing digit of hemophilic patients and rising awareness of technologically advanced products in this region.
Some of the key players in Plasma Fractionation market include Octapharma AG, Chinese Biological Products, Inc., Baxter International, Inc., Bio Products Laboratory, Grifols International SA, Shanghai Raas Blood Products Co., Ltd, Csl, Ltd., China Biologic Products, Inc., Kedrion S.P.A., Biotest, Sanquin and LFB SA.
Applications Covered:
- Rheumatology
- Immunology
- Haemato-oncology
- Critical Care
- Neurology
- Pulmonology
- Haematology
- Other Applications
End Users Covered:
- Academic Institutes
- Hospitals and Clinics
- Clinical Research Laboratories
Products Covered:
- Protease Inhibitors
- Coagulation Factor Concentrates
o Prothrombin Complex Concentrates
o Factor IX
o Von Willebrand Factor (VWF)
o Factor VIII
o Fibrinogen Concentrates
o Factor XIII
- Fractionation Process
- Albumin
- Immunoglobulin
o Subcutaneous Immunoglobulin
o Intravenous Immunoglobulin
o Other Immunoglobulins
- Other Plasma Products
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564972/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
10 Company Profiling
10.1 Octapharma AG
10.2 Chinese Biological Products, Inc.
10.3 Baxter International, Inc.
10.4 Bio Products Laboratory
10.5 Grifols International SA
10.6 Shanghai Raas Blood Products Co., Ltd
10.7 Csl, Ltd.
10.8 China Biologic Products, Inc.
10.9 Kedrion S.P.A.
10.10 Biotest
10.11 Sanquin
10.12 LFB SA
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564972/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results